Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Pilla

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Biomedicines|July 14, 2018
Immune Profiling of Cancer Patients Treated with Immunotherapy: Advances and ChallengesLorenzo Pilla, Cristina Maccalli
Expert Opinion on Biological Therapy|June 8, 2018
Methods for improving the immunogenicity and efficacy of cancer vaccinesLorenzo Pilla, Soldano Ferrone, Cristina Maccalli
Cancer Journal (Sudbury, Mass.)|September 29, 2011
Autologous versus allogeneic cell-based vaccines?Giorgio Parmiani, Lorenzo Pilla, Cristina Maccalli, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|June 7, 2006
Heat shock proteins gp96 as immunogens in cancer patientsGiorgio Parmiani, Annamaria De Filippo, Lorenzo Pilla, et al.
Expert Opinion on Biological Therapy|July 14, 2009
Multipeptide vaccination in cancer patientsLorenzo Pilla, Licia Rivoltini, Roberto Patuzzo, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2025
Advances and challenges in targeted therapies for HER2-amplified colorectal cancerMargot Pizzamiglio, Audrey Soulabaille, Widad Lahlou, et al.
Expert Review of Anticancer Therapy|August 24, 2006
Vaccination: role in metastatic melanomaLorenzo Pilla, Roberta Valenti, Andrea Marrari, et al.
Cells|March 15, 2020
New and Emerging Systemic Therapeutic Options for Advanced CholangiocarcinomaSara Massironi, Lorenzo Pilla, Alessandra Elvevi, et al.
Cancer Immunology, Immunotherapy : CII|October 13, 2006
Vaccination therapy in prostate cancerAndrea Marrari, Manuela Iero, Lorenzo Pilla, et al.
Cancers|November 25, 2020
Molecular and Immune Biomarkers for Cutaneous Melanoma: Current Status and Future ProspectsLorenzo Pilla, Andrea Alberti, Pierluigi Di Mauro, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Biomedicines|July 14, 2018
Immune Profiling of Cancer Patients Treated with Immunotherapy: Advances and ChallengesLorenzo Pilla, Cristina Maccalli
Expert Opinion on Biological Therapy|June 8, 2018
Methods for improving the immunogenicity and efficacy of cancer vaccinesLorenzo Pilla, Soldano Ferrone, Cristina Maccalli
Cancer Journal (Sudbury, Mass.)|September 29, 2011
Autologous versus allogeneic cell-based vaccines?Giorgio Parmiani, Lorenzo Pilla, Cristina Maccalli, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|June 7, 2006
Heat shock proteins gp96 as immunogens in cancer patientsGiorgio Parmiani, Annamaria De Filippo, Lorenzo Pilla, et al.
Expert Opinion on Biological Therapy|July 14, 2009
Multipeptide vaccination in cancer patientsLorenzo Pilla, Licia Rivoltini, Roberto Patuzzo, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2025
Advances and challenges in targeted therapies for HER2-amplified colorectal cancerMargot Pizzamiglio, Audrey Soulabaille, Widad Lahlou, et al.
Expert Review of Anticancer Therapy|August 24, 2006
Vaccination: role in metastatic melanomaLorenzo Pilla, Roberta Valenti, Andrea Marrari, et al.
Cells|March 15, 2020
New and Emerging Systemic Therapeutic Options for Advanced CholangiocarcinomaSara Massironi, Lorenzo Pilla, Alessandra Elvevi, et al.
Cancer Immunology, Immunotherapy : CII|October 13, 2006
Vaccination therapy in prostate cancerAndrea Marrari, Manuela Iero, Lorenzo Pilla, et al.
Cancers|November 25, 2020
Molecular and Immune Biomarkers for Cutaneous Melanoma: Current Status and Future ProspectsLorenzo Pilla, Andrea Alberti, Pierluigi Di Mauro, et al.
Pageof 4